Early or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness

Early initiation of zidovudine therapy offers a benefit that decreases over time. Symptomatic patients experience a larger benefit than asymptomatic patients. The implications beyond 3 years of follow-up remain unknown.